NASDAQ
Puma Biotechnology, Inc. (PBYI) has a free cash flow growth of 6.65% as of Friday, May 29, 2026. This represents a 88.78% decrease compared to its 12-month average of 59.27%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.